Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-21

FDA Approved: NEVIRAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Nevirapine from Mylan Pharmaceuticals Inc., resulting in a generic Nevirapine product under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nevirapine (generic) (NEVIRAPINE)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)